ResearchVEGF
Genentech Biooncology

VEGF as a predictive factor in colorectal cancer

In addition to evidence suggesting that vascular endothelial growth factor (VEGF) is a prognostic factor in colorectal cancer, recent studies have shown that VEGF may predict response to conventional systemic therapy or local radiotherapy.6,7 For more information, click on the links in the table below.

TherapyStudy Type and SizeSource
Adjuvant chemotherapy with fluoropyrimidinesRetrospective analysis (N=342)Ogata et al, Oncol Rep, 20066
Preoperative radiotherapyClinical study (N=59)Zlobec et al, Cancer, 20057


View references
for this site section